Výsledky vyhledávání

Akademický článek

Post-Marketing Surveillance Study of the Safety and Efficacy of Nalfurafine (Capsules 2.5 μg, Oral Dispersing Tablets 2.5 μg) in 1186 Patients with Chronic Liver Disease and Intractable Pruritus

Autor: Yoshitani H, Ito J, Kozono H

Publikováno v: Hepatic Medicine: Evidence and Research, Vol Volume 14, Pp 37-66 (2022)

Hiroshi Yoshitani, Junko Ito, Hideki Kozono Pharmaceutical & Medical Device Vigilance Department, Toray Industries, Inc., Tokyo, JapanCorrespondence: Hiroshi Yoshitani, Pharmaceutical & Medical Device Vigilance Department, Toray Industries, Inc., 1-1

Externí odkaz: https://doaj.org/article/ea8dd6237fea46118f7d03332ed53c3d

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Indirect suppression of CD4 T cell activation through LAG-3-mediated trans-endocytosis of MHC class II.

Autor: Wakamatsu E; Department of Immunology, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan. Electronic address: ewakama2@tokyo-med.ac.jp., Machiyama H; Department of Immunology, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan., Toyota H; Department of Immunology, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan., Takeuchi A; Department of Immunology, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan., Hashimoto R; Department of Immunology, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan., Kozono H; Institute for Quantum Life Science, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba-shi, Chiba 263-8555, Japan., Yokosuka T; Department of Immunology, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan. Electronic address: yokosuka@tokyo-med.ac.jp.

Publikováno v: Cell reports [Cell Rep] 2024 Sep 24; Vol. 43 (9), pp. 114655. Date of Electronic Publication: 2024 Aug 26.

Zobrazit plný text záznamu

Akademický článek

Post-marketing surveillance study of the safety and efficacy of nalfurafine hydrochloride (Remitch® capsules 2.5 μg) in 3,762 hemodialysis patients with intractable pruritus

Autor: Kozono H, Yoshitani H, Nakano R

Publikováno v: International Journal of Nephrology and Renovascular Disease, Vol Volume 11, Pp 9-24 (2018)

Hideki Kozono,* Hiroshi Yoshitani,* Ryoko Nakano* Pharmaceutical and Medical Device Vigilance Department, Toray Industries, Inc., Tokyo, Japan *The authors contributed equally to this work Background: Intractable pruritus in hemodialysis patients can

Externí odkaz: https://doaj.org/article/5c886b6d3ded4a43b19fdd00e167a730

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Ubiquitination of Major Histocompatibility Complex II Changes Its Immunological Recognition Structure.

Autor: Kozono Y; Research Institute for Biomedical Sciences, Tokyo University of Sciences, Noda 278-0022, Chiba, Japan., Kuramochi M; Graduate School of Science and Engineering, Ibaraki University, Hitachi 316-0033, Ibaraki, Japan., Sasaki YC; Department of Advanced Material Science, Graduate School for Frontier Sciences, The University of Tokyo, Kashiwa 277-8568, Chiba, Japan.; AIST-U Tokyo Advanced Operando Measurement Technology Innovation Laboratory (OPERANDO-OIL), National Institute of Advanced Industrial Science and Technology (AIST), 6-2-3 Kashiwanoha, Kashiwa 277-0882, Chiba, Japan.; Japan Synchrotron Radiation Research Institute, SPring-8, 1-1-1 Kouto, Sayo 679-5198, Hyogo, Japan., Kozono H; Research Institute for Biomedical Sciences, Tokyo University of Sciences, Noda 278-0022, Chiba, Japan.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2023 Dec 03; Vol. 24 (23). Date of Electronic Publication: 2023 Dec 03.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Elucidation of binding mechanism, affinity, and complex structure between mWT1 tumor-associated antigen peptide and HLA-A*24:02.

Autor: Bekker GJ; Institute for Protein Research, Osaka University, Suita, Osaka, Japan., Numoto N; Medical Research Institute, Tokyo Medical and Dental University (TMDU), Tokyo, Japan., Kawasaki M; Graduate School of Life and Environmental Sciences, Kyoto Prefectural University, Kyoto, Kyoto, Japan., Hayashi T; Graduate School of Life and Environmental Sciences, Kyoto Prefectural University, Kyoto, Kyoto, Japan., Yabuno S; Graduate School of Life and Environmental Sciences, Kyoto Prefectural University, Kyoto, Kyoto, Japan., Kozono Y; Research Institute for Biomedical Sciences, Tokyo University of Science, Noda, Chiba, Japan., Shimizu T; Department of Immunology, Kochi Medical School, Kochi University, Nankoku-shi, Kochi, Japan., Kozono H; Research Institute for Biomedical Sciences, Tokyo University of Science, Noda, Chiba, Japan., Ito N; Medical Research Institute, Tokyo Medical and Dental University (TMDU), Tokyo, Japan., Oda M; Graduate School of Life and Environmental Sciences, Kyoto Prefectural University, Kyoto, Kyoto, Japan., Kamiya N; Graduate School of Information Science, University of Hyogo, Kobe, Hyogo, Japan.

Publikováno v: Protein science : a publication of the Protein Society [Protein Sci] 2023 Oct; Vol. 32 (10), pp. e4775.

Zobrazit plný text záznamu

Akademický článek

Meningitis caused by Chromobacterium haemolyticum suspected to be derived from a canal in Japan: a case report.

Autor: Iwamoto K; Department of Medical Laboratory, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan., Yamamoto M; Department of Clinical Laboratory Medicine, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawaharacho, Sakyo-Ku, Kyoto, 6068507, Japan. masakiy@kuhp.kyoto-u.ac.jp., Yamamoto A; Department of Cerebral Neurology and Stroke, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan., Sai T; Department of Cerebral Neurology and Stroke, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan., Mukai T; Department of Medical Laboratory, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan., Miura N; Department of Medical Laboratory, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan., Kozono H; Department of Medical Laboratory, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan., Onishi S; Department of Medical Laboratory, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan., Ohno S; Department of Infection Control, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan., Iwamoto N; Department of Clinical Laboratory Medicine, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawaharacho, Sakyo-Ku, Kyoto, 6068507, Japan., Matsumura Y; Department of Clinical Laboratory Medicine, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawaharacho, Sakyo-Ku, Kyoto, 6068507, Japan., Nagao M; Department of Clinical Laboratory Medicine, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawaharacho, Sakyo-Ku, Kyoto, 6068507, Japan., Urata Y; Department of Medical Laboratory, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.

Publikováno v: Journal of medical case reports [J Med Case Rep] 2023 Apr 30; Vol. 17 (1), pp. 171. Date of Electronic Publication: 2023 Apr 30.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Vyhledávací nástroje:

Upřesnit hledání